JAMES HEALY Insider Trading $EDGE PDS Biotechnology Corp
Get free email notifications about insider trading for JAMES HEALY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES HEALY. JAMES HEALY is Director in AMARIN CORP PLC\UK ($AMRN) and Director in INTERMUNE INC ($ITMN) and Director in HYPERION THERAPEUTICS INC ($HPTX) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Bolt Biotherapeutics, Inc. ($BOLT) and in Natera, Inc. ($NTRA) and Director in Natera, Inc. ($NTRA) and Director in Iterum Therapeutics plc ($ITRM) and Director in Y-mAbs Therapeutics, Inc. ($YMAB) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX).
JAMES HEALY in PDS Biotechnology Corp
Trading Symbol: EDGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES HEALY: Director
Holdings: 2,852,711 shares
Current Value: $27,243,390
Latest Transaction: Jun 21 2017
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES HEALY in PDS Biotechnology Corp
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, BOLT, CHRS, HPTX, ITMN, ITRM, KRTX, NTRA, EDGE, YMAB
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2017 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Option Exercise | A | 10.15 | 15,000 | 152,250 | 15,000 | |
Jun 23 2016 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Option Exercise | A | 9.34 | 15,000 | 140,100 | 15,000 | |
Mar 15 2016 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | P | 7.30 | 541,343 | 3,951,641 | 2,852,711 | 2.3 M to 2.9 M (+23.42 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Option Exercise | C | 0.00 | 2,473,118 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | J | 8.60 | 53,665 | 461,519 | 2,311,368 | 2.3 M to 2.3 M (+2.38 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | P | 11.00 | 450,000 | 4,950,000 | 2,257,703 | 1.8 M to 2.3 M (+24.89 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | HEALY JAMES | Director | Buy | C | 0.00 | 1,807,703 | 0 | 1,807,703 | 0 to 1.8 M |
Page: 1